Found: 8
Select item for more details and to access through your institution.
Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 462, doi. 10.46883/2024.25921032
- By:
- Publication type:
- Article
3 Things You Should Know About Immunotherapy in DLBCL.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 478
- By:
- Publication type:
- Article
Experts' Perspectives on Pancreatic Cancer Treatment.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 476
- Publication type:
- Article
Efficacy and Safety of Zolbetuximab in Gastric Cancer.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 472, doi. 10.46883/2024.25921031
- By:
- Publication type:
- Article
Zolbetuximab's Impact on Gastric/GEJ Adenocarcinoma.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 470
- Publication type:
- Article
3 Things You Should Know About Hemolytic Anemias.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 482
- By:
- Publication type:
- Article
Approaching End-of-Life Discussions With Directness and Compassion.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 458
- By:
- Publication type:
- Article
Assessing 2024 Oncology Advances and Looking Ahead.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 12, p. 457
- By:
- Publication type:
- Article